We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Innovative Device Measures Glucose in Saliva for More Convenient Diabetes Monitoring

By LabMedica International staff writers
Posted on 30 Aug 2023

Diabetes arises when the body fails to regulate its blood glucose levels. More...

Elevated glucose levels can lead to cardiovascular disease and other ailments, making it essential for individuals with diabetes to keep their blood glucose within moderate ranges. The conventional method for monitoring blood glucose in people with diabetes involves using devices that analyze a droplet of blood obtained through finger pricking multiple times daily. Recently, implanted sensors have enabled continuous glucose monitoring without the discomfort of pinpricks, but these devices might be less accurate for lower glucose levels and are not approved for children. A more convenient alternative could be salivary testing, as saliva correlates with blood glucose levels. However, glucose concentrations in saliva are much lower than in blood, posing challenges for accurate measurement without advanced laboratory equipment.

Researchers at King Abdullah University of Science and Technology (KAUST, Saudi Arabia) have now created a prototype sensor capable of measuring glucose levels in saliva. This innovation could eventually offer a simple, swift, and painless way for individuals to monitor their diabetes. The KAUST team devised a remarkably sensitive glucose detector built on a thin-film transistor. These compact, lightweight, and energy-efficient devices could be produced en masse as affordable disposable sensors. The transistor features thin layers of semiconductors, including indium oxide and zinc oxide, along with the enzyme glucose oxidase on top. When a saliva sample is applied to the sensor, the enzyme converts any glucose present into D-gluconolactone and hydrogen peroxide. The electrical oxidation of hydrogen peroxide generates electrons that enter the semiconductor layers, modifying the current flowing through the semiconductors. This change reflects the glucose concentration in the sample.

The researchers evaluated their device using human saliva samples with varying glucose levels and also analyzed saliva from fasting volunteers (since saliva glucose levels might not align with blood glucose levels immediately after eating). They discovered that the device accurately measured a broad range of glucose concentrations in under a minute. Importantly, the sensor remained unaffected by other molecules in saliva, including sugar derivatives like fructose and sucrose. Although the device's sensitivity decreased over time, it maintained good performance even after two weeks of storage at room temperature. The team is presently working on an array of transistor sensors that could simultaneously detect multiple metabolites in saliva.

“An easy-to-use noninvasive glucose-measuring device using saliva as a medium could be life-changing for millions of patients worldwide,” said research team member Abhinav Sharma.

“The development of portable sensor arrays that can be integrated with a smartphone is a potential future direction for research,” added Thomas Anthopoulos, who led the research team.

Related Links:
KAUST 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gastrointestinal Panel
Xpert® GI Panel
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.